179 related articles for article (PubMed ID: 32986928)
1. Pathophysiology of coronavirus disease 2019 for wound care professionals.
Al-Benna S
Int Wound J; 2020 Dec; 17(6):1935-1940. PubMed ID: 32986928
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
6. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
9. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
10. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
11. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
[TBL] [Abstract][Full Text] [Related]
12. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.
Mariappan V; S R R; Balakrishna Pillai A
IUBMB Life; 2020 Dec; 72(12):2533-2545. PubMed ID: 33031602
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy approaches on innate immunity for SARS-Cov-2.
Arslan BA; Timucin AC
Acta Virol; 2020; 64(4):389-395. PubMed ID: 32985199
[TBL] [Abstract][Full Text] [Related]
17. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
18. Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.
Fialkowski A; Gernez Y; Arya P; Weinacht KG; Kinane TB; Yonker LM
Pediatr Pulmonol; 2020 Oct; 55(10):2556-2564. PubMed ID: 32710693
[TBL] [Abstract][Full Text] [Related]
19. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
20. Complement Factors in COVID-19 Therapeutics and Vaccines.
Kurtovic L; Beeson JG
Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
